Conclusions: Cytokeratin 5 is expressed in a significant proportion of
epithelial ovarian cancers and represents a slower proliferating
chemoresistant subpopulation that may warrant cotargeting in combination
therapy.
0
comments
:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.